Management of Severe Hypertension with Elevated Troponin

Immediate Assessment and Diagnosis

The European Society of Cardiology recommends obtaining a 12-lead ECG immediately to assess for ST-segment elevation, which determines the entire treatment pathway 1, 2
The European Society of Cardiology suggests performing urgent echocardiography to evaluate left ventricular function, regional wall motion abnormalities, and exclude mechanical complications 1, 2
The European Society of Cardiology recommends checking for signs of acute end-organ damage: pulmonary edema, acute heart failure, neurological deficits, or renal dysfunction 3

The European Society of Cardiology recommends treating hypertension promptly with IV nitrates as first-line therapy, NOT beta-blockers or calcium channel blockers in the acute setting 1, 3
The American College of Cardiology recommends starting IV nitroglycerin at 10-20 mcg/min, increasing by 5-10 mcg/min every 3-5 minutes as tolerated, to target initial BP reduction of approximately 30 mmHg within the first hour 4
The European Society of Cardiology recommends avoiding reducing systolic BP below 100 mmHg, as this may worsen myocardial perfusion 1, 5
The European Society of Cardiology suggests adding IV sodium nitroprusside for very severe cases if nitroglycerin insufficient 1, 3

The European Society of Cardiology recommends initiating dual antiplatelet therapy immediately with aspirin 150-300 mg chewed or 75-250 mg IV, and adding ticagrelor or prasugrel (or clopidogrel if others contraindicated) if Type 1 MI suspected (thrombotic ACS) 1, 2
The European Society of Cardiology recommends starting weight-adjusted low molecular weight heparin (enoxaparin 30 mg IV bolus followed by 1 mg/kg subcutaneous every 12 hours) if Type 1 MI suspected (thrombotic ACS) 1

The European Society of Cardiology recommends immediate PCI if ST-segment elevation present, cardiogenic shock develops, or recurrent ischemia despite medical therapy 1, 2
The European Society of Cardiology suggests considering early angiography (within 24-72 hours) if high-risk features present (elevated troponin with ongoing chest pain, hemodynamic instability, or arrhythmias) 9

The European Society of Cardiology recommends initiating guideline-directed medical therapy once hemodynamically stable, including ACE inhibitor (or ARB if intolerant) starting within 24 hours for all patients with heart failure, LV dysfunction (LVEF <40%), diabetes, or anterior MI 1, 2
The European Society of Cardiology recommends starting beta-blocker after stabilization for patients with LVEF <40% or heart failure 1, 2
The European Society of Cardiology recommends starting high-intensity statin as early as possible 2
The European Society of Cardiology recommends starting aldosterone antagonist if LVEF <40% with heart failure or diabetes, provided no severe renal failure or hyperkalemia 1, 2

The European Society of Cardiology recommends continuous cardiac monitoring for arrhythmias 1
The American College of Cardiology recommends monitoring blood pressure every 5-15 minutes during IV vasodilator titration 4
The American College of Cardiology recommends monitoring urine output (place bladder catheter if furosemide given) 4, 8
The European Society of Cardiology recommends serial troponin measurements to assess for ongoing myocardial injury 1
The American College of Cardiology recommends monitoring electrolytes and renal function within 6-24 hours, especially if diuretics used 8